Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Santhera Pharmaceuticals Holding AG    SANN   CH0027148649

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
04/12/2019 04/15/2019 04/16/2019 04/17/2019 04/18/2019 Date
15.52(c) 16.3(c) 16.4(c) 15.96(c) 15.88(c) Last
14 005 89 269 42 985 39 214 4 724 Volume
-1.15% +5.03% +0.61% -2.68% -0.50% Change
More quotes
Financials (CHF)
Sales 2018 27,3 M
EBIT 2018 -29,9 M
Net income 2018 6,00 M
Finance 2018 1,56 M
Yield 2018 -
Sales 2019 36,1 M
EBIT 2019 -37,6 M
Net income 2019 -23,0 M
Finance 2019 32,2 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 6,43x
EV / Sales2019 4,02x
Capitalization 177 M
More Financials
Company
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s... 
Sector
Pharmaceuticals
Calendar
04/28Presentation
More about the company
Surperformance© ratings of Santhera Pharmaceuticals H
Trading Rating : - Investor Rating :
More Ratings
Latest news on SANTHERA PHARMACEUTICALS H
04/16SANTHERA PHARMACEUTICALS : to Present Long-term Efficacy Results with Idebenone ..
AQ
04/15SANTHERA PHARMACEUTICALS : to Present Long-term Efficacy Results with Idebenone ..
AQ
04/05SANTHERA PHARMACEUTICALS : Raises up to CHF 22.1 Million by Placement of Shares ..
AQ
04/04SANTHERA PHARMACEUTICALS : Raises up to CHF 22.1 Million by Placement of Shares ..
GL
04/03SANTHERA PHARMACEUTICALS : Provides Update on Near-term Corporate Financing Init..
GL
03/30SANTHERA PHARMACEUTICALS : Filing for EMA Conditional Marketing Authorization fo..
AQ
03/29SANTHERA PHARMACEUTICALS : Provides Update on Filing for Conditional Marketing A..
AQ
03/12SANTHERA PHARMACEUTICALS : Completes Patient Enrollment in Phase IV Long-term St..
PU
03/12SANTHERA PHARMACEUTICALS : Completes Patient Enrollment in Phase IV Long-term St..
GL
02/27SANTHERA PHARMACEUTICALS : Santheras Syros succesful in DMD study
AQ
More news
Analyst Recommendations on SANTHERA PHARMACEUTICALS H
More recommendations
Sector news : Specialty & Advanced Pharmaceuticals
11:53aTEVA PHARMACEUTICAL INDUSTRIES : Pharma Gets FDA Approval to Market Generic Nasa..
DJ
04/18Pfizer, Lilly Release Top-Line Results From Phase 3 Study of Tanezumab for Os..
DJ
04/18Pfizer, Johnson & Johnson Weigh on Pharmaceutical ETFs
DJ
04/17ACREAGE : Canopy Growth nearing deal to buy U.S.-based pot company Acreage Holdi..
RE
04/17MERCK AND : on Pace for Largest Percent Decrease in Over a Year -- Data Talk
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Chart SANTHERA PHARMACEUTICALS HOLDING AG
Duration : Period :
Santhera Pharmaceuticals Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANTHERA PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 8,00  CHF
Spread / Average Target -50%
EPS Revisions
Managers
NameTitle
Thomas Meier Chief Executive Officer & Director
Elmar J. Schnee Chairman
Christoph Rentsch Chief Financial Officer
Kristina Sjöblom Nygren Chief Medical Officer, EVP & Head-Development
Kristina Sjoblom Nygren Chief Medical Officer & Head-Development
Sector and Competitors